CORT - Company ID 0001088856
The table below shows CORCEPT THERAPEUTICS INC's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $120.50M | $127.67M | $135.55M | $66.33M | $77.62M | $76.19M |
| Short-term investments | $251.66M | $255.67M | $232.67M | - | - | - |
| Receivables | $59.79M | $53.98M | $41.12M | $31.06M | $27.63M | $26.20M |
| Inventory | $12.87M | $12.41M | $7.73M | $6.10M | $4.99M | $4.91M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $485.46M |
| $471.60M |
| $458.64M |
| $499.25M |
| $266.46M |
| $478.50M |
| Property, plant & equipment | $1.89M | $2.69M | $195.00K | $633.00K | $1.00M | $1.68M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $836.65M | $840.55M | $621.52M | $583.43M | $423.76M | $571.73M |
| Accounts payable | $40.44M | $15.38M | $17.40M | $11.98M | $6.91M | $10.55M |
| Total current liabilities | $166.09M | $140.77M | $104.50M | $72.49M | $47.54M | $47.49M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $188.85M | $160.96M | $114.81M | $81.59M | $47.95M | $48.39M |
| Retained earnings | $643.39M | $543.74M | $402.53M | $296.39M | $194.97M | $82.46M |
| Total equity | $647.80M | $679.59M | $506.70M | $501.84M | $375.81M | $523.34M |